Overview

Efficacy, Safety, Tolerability and Pharmacokinetics of BIBN 4096 BS Versus Placebo in the Treatment of a Single Attack of Acute Migraine Headache

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

Efficacy, Safety, Tolerability and Pharmacokinetics of BIBN 4096 BS in patients with a single acute migraine attack with or without aura

Phase:

Phase 2

Details

Lead Sponsor:

Boehringer Ingelheim